and Law and co-chairs a subcommittee on the Reference Manual on Scientific Evidence. She also serves on a National Academy Committee on Identifying the Needs of the Forensic Science Community, and on a Committee on Assuring the Integrity of Research Data.
Kirsten Bibbins-Domingo, Ph.D., M.D., MAS-CR, is an Assistant Professor of Medicine and of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). She is the co-director of the UCSF Center for Vulnerable Populations and an attending physician at San Francisco General Hospital. Dr. Bibbins-Domingo received her A.B. from Princeton University and her Ph.D. in biochemistry, her M.D. and her Masters of Clinical Research from UCSF. She completed her residency in internal medicine at UCSF that included training at the San Francisco Veterans Administration Medical Center (SFVAMC) and continues to have several active collaborations with researchers in epidemiology and health services at the SFVAMC. Dr. Bibbins-Domingo’s research interests include the epidemiology of cardiovascular disease, race and gender health and health-care disparities, and the quality of cardiovascular care, particularly heart failure disease management. She has published original research on the development of risk factors for cardiovascular disease, including diabetes, impaired kidney function, and high blood pressure, as well as the use of novel biomarkers as diagnostic and screening tests for cardiovascular disease.
Eric G. Bing, M.D., Ph.D., M.P.H., is the Endowed Professor of Global Health and HIV Research at the Charles Drew University of Medicine and Science in Los Angeles. He is the Director of the Drew Center for AIDS Research, Education and Services (Drew CARES), the Institute for Community Health Research and co-director of the Center for HIV Identification, Prevention and Treatment Services (CHIPTS). Dr. Bing’s research interests include mental health care, substance abuse treatment, community mobilization, service systems, and HIV prevention research in civilian and military settings in the United States and abroad. He works with militaries in multiple countries in developing disease prevention programs for soldiers. Dr. Bing received his M.D. from Harvard Medical School and his M.P.H. and Ph.D. in epidemiology from the University of California, Los Angeles’s (UCLA’s) School of Public Health. He completed his psychiatric training at the UCLA Neuropsychiatric Institute/West Los Angeles VA Medical Center. Dr. Bing served as a member of the National Academies’ Ryan White CARE Act committee.
Bernard D. Goldstein, M.D., is the former Dean of the University of Pittsburgh’s Graduate School of Public Health and remains active as a professor in the Department of Environmental and Occupational Health. Dr. Goldstein’s research interests include risk assessment, toxicology, workplace hazards, internal medicine, preventive medicine, occupational and environmental medicine, and environmental health policy. He has conducted research on air quality and leukemia and various aspects of public health decision making. Dr. Goldstein was the founder and former Director of the Environmental and Occupational Sciences Institute at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Dr. Goldstein also served as Assistant Administrator for Research and Development at the U.S. Environmental Protection Agency. He received his M.D. from the New York University School of Medicine. Dr. Goldstein was elected to the Institute of Medicine in 1991 (Section 9) and has served as a member and chair of numerous committees for the National Academies which address subjects including risk assessment methodology, exposure to radioactive materials, and biological